Archives: Speakers

Gilad Beck serves as the Natick, MA Site Head, Operations and Manufacturing Director at Orgenesis. He holds a BSc in Biotechnology and has over 10 years of experience working in the cell and gene therapy industry, in leading manufacturing, process development and project management roles. His background includes extensive knowledge of various cell and gene therapy processes, process development, tech transfer, closed and automated systems and GMP operations. Mr. Beck is also an expert in building cross-functional high performing teams. He utilizes his skills and experience to lead the Natick, MA site set up and operations as part of Orgenesis’ POCare Network that brings together patients, doctors, industry partners, research institutes and hospitals worldwide to achieve harmonized, regulated clinical development and production of life-saving therapies.

Rakib Ouro-Djobo is an empowering servant and a dedicated supply chain management leader focused on providing global access to life-saving treatments and life-changing opportunities. He has over 12 years of experience supporting mission-driven organizations in the life science and biotech industries. Currently, he works as the Clinical Supply Chain Lead for the Bill & Melinda Gates Medical Research Institute.

Sarah Mandlebaum is a dedicated sustainability professional serving as the Lead for Global Environmental Sustainability & Life Cycle Assessment at Takeda in Lexington, Massachusetts. With a strong foundation in sustainability, she currently leads Takeda’s work around measuring the sustainability performance of Takeda’s products. Sarah holds a Master of Business Administration (MBA) from the Yale School of Management and a Master of Public Health (MPH) in Environmental Health from the University of Michigan.

Jessica Vieira, PhD, leads the global value chain environmental sustainability strategy at Takeda Pharmaceutical Company. She has a decade of experience in environmental sustainability strategy across the chemical, consumer electronics and food technology industries and holds a PhD focused on life cycle assessment as well as a background in environmental engineering. In her role at Takeda, Jessica leads the Scope 3 greenhouse gas emissions reduction program aimed at achievement of the company’s goal to reach net-zero across the value chain before 2040.

Sydney Reynolds, PharmD, MS, is the First Year Global Clinical Supply Chain Fellow at Takeda. Sydney graduated in May of 2023 from The Ohio State University College of Pharmacy with her PharmD and MS in Translational Pharmacology specializing in Clinical Pharmacology and Clinical Trial Design. Before that, she received her BS in Chemistry and Biology from the University of Indianapolis. Throughout pharmacy school, she was a Clinical Pharmacy Intern at The OSU James Cancer Hospital, where she was also heavily involved in research. She held leadership positions in Student College of Clinical Pharmacy (SCCP) and was a PharmD Ambassador for the college. For Sydney, pharmaceutical research is where her two passions collide – science and healthcare. She is excited to jumpstart her career with her fellowship and begin improving the lives of patients in the biopharmaceutical industry.

Anthony has worked for the FDA since April of 2010 as an investigator in the BIMO, Foods and now import program area’s.

Swathi is an experienced and successful leader with over 12 years of Pharmaceutical, Biologics, and Medical Device experience specializing in submissions to global health authorities.   She has led large diverse teams to ensure regulatory submission success from investigational, marketing, and post-marketing submissions.   Swathi holds a Master of Science degree in Regulatory Affairs, as well as RA Certifications from RAPS in both the US and EU.  With a unique combination of Regulatory Affairs and submissions experience, she drives the teams with best practices for methodical planning, efficient development, and management of multi-country dossiers.